Results 51 to 60 of about 36,244 (312)

Human vaccines industry in China, 2019: Part—I

MGM Journal of Medical Sciences, 2020
China is presently the most populous country; the annual birth rate is estimated at above 18 million each year over the next 5 years. The number of the aged population is also increasing.
Prasanta Kumar Ghosh
doaj   +1 more source

Reacciones post vacuna SINOPHARM COVID-19 en el personal de salud -Huancayo 2021.

, 2022
In a global effort to combat the COVID-19 pandemic, vaccination against COVID-19 begins in Peru on February 9, 2021, with priority vaccinating health personnel with the SINOPHARM vaccine.
Martínez Véliz , Marivel Rosa, Poma Salinas , Jenny Giovanna, Garcia Inga , Belinda Olga, Cuadros Ríos , Rosario Eleana   +3 more
core   +1 more source

Awareness, Practice, and Acceptance of COVID-19 Vaccination among Medical Students from Mansoura University, Egypt: A Cross-sectional Survey [PDF]

International Journal of Epidemiologic Research, 2022
Background and aims: The coronavirus disease 2019 (COVID-19) is an emerging transmissible infection that can be prevented by proper hygiene measures and vaccination.
Basant Katamesh, Moustafa Katamesh, W. Abdalrhman, Rawan ElDeeb, Nourhan Hareera, Ahmed Raslan, Ahmed Alabd, Ensanya Abou Neel   +7 more
doaj   +1 more source

Short-Term Side Effects of Sinopharm Coronavirus Disease 2019 Vaccine in Adolescents Aged 12-18 Years Vaccinated in Dr. Masih Daneshvari Hospital

Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, 2022
BACKGROUND: Vaccination is known as one of the best approaches for overcoming the coronavirus disease 2019 (COVID-19) pandemic. Many COVID-19 vaccines were authorized for emergency use, and the knowledge about efficacy, safety, and adverse effects of ...
Parisa Honarpisheh, Zahra Nematollahi, Mojgan Palizdar, Azade Zeinab Mirzaee, Elham Askari, Vahab Rekabi, Zahra Daneshmandi, Parsa Jamilian, Maryam Hassanzad, Mahsa Rekabi   +9 more
doaj   +1 more source

Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection.

, 2022
The kinetics and magnitude of antibody responses to different proteins of the SARS-CoV-2 virus in Sinopharm/BBIBP-CorV vaccinees has not been previously studied. Therefore, we investigated antibody responses to different SARS-CoV-2 proteins at 2 weeks, 3
Thushali Ranasinghe, Maneshka Karunanada, Graham S Ogg, Gathsaurie Neelika Malavige, Chandima Jeewandara, Shashika Dayarathna, Achala Kamaladasa, Thashmi Nimasha, Inoka Sepali Aberathna, Lahiru Perera, Jeewantha Jayamali   +10 more
core   +1 more source

Evaluation of the effectiveness and adverse effects of COVID-19 vaccines administered at Kashan University of Medical Sciences [PDF]

International Archives of Health Sciences
Objectives: The development of protective immunity through COVID-19 vaccines is influenced by both host factors and the composition of the vaccine. Therefore, it is essential to assess the efficacy and side effects of different vaccines among individuals
Zahra Soleimani, Kamal Esalatmanesh, Mohammad Mehdi Safaaddin Kashani, Mohamadjavad Azadchehr, Roozbeh Esalatmanesh   +4 more
doaj   +1 more source

Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report

Journal of Medical Case Reports, 2023
Abstract Background Vaccine-induced thrombotic thrombocytopenia is associated with the coronavirus disease 2019 vaccines. It has been reported by vector-based vaccines. To the best of our knowledge, there is no report about vaccine-induced thrombotic thrombocytopenia in whole-virus vaccines.
Mohammad Sistanizad, Tahereh Sabaghian, Hossein Amini, Fahimeh Hadavand, Mahmood Nabavi, Mehran Kouchek, Mir Mohammad Miri, Sara Salarian, Seyedpouzhia Shojaei, Omid Moradi   +9 more
openaire   +3 more sources

COVID-19 immunoglobulins response for COVID-19 confirmed patients (n = 233), Pfizer-BioNTech vaccine recipients (n = 141), Sinopharm vaccine recipients (n = 147), and random patients (n = 144).

, 2023
COVID-19 immunoglobulins response for COVID-19 confirmed patients (n = 233), Pfizer-BioNTech vaccine recipients (n = 141), Sinopharm vaccine recipients (n = 147), and random patients (n = 144).
Amjed A. Tarifi (14614630), Arwa Qaqish (14614633), Jumanah Abu-Raideh (14614642), Manal M. Abbas (14614636), Muna Salameh (14614645), Mohammad Al-Tamimi (14532415), Hadeel Albalawi (14614639), Ashraf I. Khasawneh (14614648)   +7 more
core   +1 more source

Análisis de la ética periodística de un programa de entrevistas sobre la eficacia de la vacuna Sinopharm, Perú, 2021 [PDF]

, 2023
El objetivo del estudio se centró en analizar cómo se manejó la ética periodística de un programa de entrevistas sobre la eficacia de la vacuna Sinopharm, Perú, 2021. Asimismo, se consideró conveniente utilizar el enfoque cualitativo, método inductivo,
Gonzales Pacheco, Maria Alexssandra, Castillo Aguilar, Viyú Maria   +1 more
core  

Characteristics of patients who received Sinopharm BIPB vaccine in Singapore general practice

Singapore Medical Journal
Edwin Aik Chen, Chng, Aloysius, Chow, Helen Elizabeth, Smith   +2 more
openaire   +3 more sources